20,23‐dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF‐κB activity in human keratinocytes
- 17 December 2009
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 223 (1) , 36-48
Abstract
We have examined effects of the 20,23‐dihydroxyvitamin D3 (20,23(OH)2D3), on differentiation and proliferation of human keratinocytes and the anti‐inflammatory potential of 20,23(OH)2D3 from its action on nuclear factor‐κB (NF‐κB). 20,23(OH)2D3 inhibited growth of keratinocytes with a potency comparable to that for 1,25‐dihydroxyvitamin D3 (1,25(OH)2D3). Cell cycle analysis showed that this inhibition was associated with G1/G0 and G2/M arrests. 20,23(OH)2D3 stimulated production of involucrin mRNA and inhibited production of cytokeratin 14 mRNA in a manner similar to that seen for 1,25(OH)2D3. Flow cytometry showed that these effects were accompanied by increased involucrin protein expression, and an increase in the cell size and granularity. Silencing of the vitamin D receptor (VDR) by corresponding siRNA abolished the stimulatory effect on involucrin gene expression demonstrating an involvement of VDR in 20,23(OH)2D3 action. This mode of action was further substantiated by stimulation of CYP24 gene expression and stimulation of the CYP24 promoter‐driven reporter gene activity. 20,23(OH)2D3 displayed several fold lower potency for induction of CYP24 gene expression than 1,25(OH)2D3. Finally, 20,23(OH)2D3 inhibited the transcriptional activity of NF‐κB in keratinocytes as demonstrated by EMSA, NF‐κB‐driven reporter gene activity assays and measurements of translocation of p65 from the cytoplasm to the nucleus. These inhibitory effects were connected with stimulation of the expression of IκBα with subsequent sequestration of NF‐κB in the cytoplasm and consequent attenuation of transcriptional activity. In summary, we have characterized 20,23(OH)2D3 as a novel secosteroidal regulator of keratinocytes proliferation and differentiation and a modifier of their immune activity. J. Cell. Physiol. 223: 36–48, 2010.Keywords
This publication has 49 references indexed in Scilit:
- 20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human KeratinocytesPLOS ONE, 2009
- Sequential Metabolism of 7-Dehydrocholesterol to Steroidal 5,7-Dienes in Adrenal Glands and Its Biological Implication in the SkinPLOS ONE, 2009
- 20-Hydroxyvitamin D3, a Product of Vitamin D3 Hydroxylation by Cytochrome P450scc, Stimulates Keratinocyte DifferentiationJournal of Investigative Dermatology, 2008
- Pathways and products for the metabolism of vitamin D3 by cytochrome P450sccThe FEBS Journal, 2008
- Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrinThe International Journal of Biochemistry & Cell Biology, 2008
- CRH inhibits NF-κB signaling in human melanocytesPeptides, 2006
- Resurrection of vitamin D deficiency and ricketsJournal of Clinical Investigation, 2006
- An alternative pathway of vitamin D2 metabolismThe FEBS Journal, 2006
- HaCaT Cell Line as a Model System for Vitamin D3 Metabolism in Human SkinJournal of Investigative Dermatology, 1997
- Purification of cytochrome P-450D1α (25-hydroxyvitamin D3-1α-hydroxylase) of bovine kidney mitochondriaBiochemical and Biophysical Research Communications, 1982